Viewing Study NCT04111458


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-01-05 @ 6:35 PM
Study NCT ID: NCT04111458
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-25
First Post: 2019-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module